Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007589,
umls-concept:C0010711,
umls-concept:C0012426,
umls-concept:C0040845,
umls-concept:C0086045,
umls-concept:C0086418,
umls-concept:C0205174,
umls-concept:C0205178,
umls-concept:C0205195,
umls-concept:C0205251,
umls-concept:C0205263,
umls-concept:C0368761,
umls-concept:C0439677,
umls-concept:C1511938
|
pubmed:issue |
1
|
pubmed:dateCreated |
1990-4-10
|
pubmed:abstractText |
Differentiation induction therapy provides an alternative for treatment of patients with acute myeloid leukaemia (AML) who are either unsuitable for or unresponsive to conventional cytotoxic chemotherapy. The effect of a triple combination of retinoic acid (RA) + low concentration of cytarabine (Ara-C) + dimethylformamide (DMF) on the differentiation of blasts from 24 AML patients was studied. Nonadherent mononuclear cells were cultured at a concentration of 5 x 10(5) cells/ml in 24-well tissue culture plates containing RPMI 1640 culture medium with 20% fetal calf serum, 10% autologous serum and 10% 5637-conditioned medium and incubated with 10(-6) M RA, 10(-6) M Ara-C and/or 100 mM DMF alone and in combination with each other for 6 days in primary culture at 37 degrees C in a humidified incubator under 5% CO2. The triple combination of 10(-6) M RA + 10(-6) M Ara-C + 100 mM DMF induced 90% of blasts from 22 out of 24 AML patients to differentiate. These highly effective results justify a clinical trial of this triple combination for AML patients who are either unsuitable for or unresponsive to conventional cytotoxic chemotherapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0009-3157
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
51-7
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:2307025-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:2307025-Cell Transformation, Neoplastic,
pubmed-meshheading:2307025-Cytarabine,
pubmed-meshheading:2307025-Dimethylformamide,
pubmed-meshheading:2307025-Humans,
pubmed-meshheading:2307025-Leukemia, Myeloid, Acute,
pubmed-meshheading:2307025-Tretinoin
|
pubmed:year |
1990
|
pubmed:articleTitle |
Triple combination of retinoic acid, low concentration of cytarabine and dimethylformamide induces differentiation of human acute myeloid leukaemic blasts.
|
pubmed:affiliation |
Department of Haematological Medicine, University of Cambridge Clinical School, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|